(NASDAQ:CRMT), NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of America's Car-Mart, Inc. (NASDAQ: CRMT) resulting from allegations that America's Car-Mart may have issued materially misleading business information to the investing public. SO WHAT: If […]

CRMT Investor News: If You Have Suffered Losses in America's Car-Mart, Inc. (NASDAQ: CRMT), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire December 09, 2025 NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on

NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of investors in cryptocurrency issued by Balancer (ticker: BAL), resulting from allegations that Balancer may have issued materially misleading business information to the investing public. SO WHAT: If

Balancer Announcement: If You Have Suffered Losses in Balancer Cryptocurrency, You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire December 09, 2025 NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of investors

(NASDAQ:BMEA), Key Opinion Leader, Dr. Ralph DeFronzo presents the “Future of Menin Inhibitors” and discusses icovamenib and its clinical results shared during WCIRDC 2025 in online interview SAN CARLOS, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Biomea Fusion, Inc. (Nasdaq: BMEA), a clinical stage diabetes and obesity company, today announced the release of a KOL

Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025 GlobeNewswire December 09, 2025 Key Opinion Leader, Dr. Ralph DeFronzo presents the “Future of Menin Inhibitors” and discusses icovamenib and its clinical results shared during WCIRDC 2025 in online interview SAN CARLOS, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) — Biomea Fusion,

TELUS announced today it has successfully closed its previously announced offering of US$1.5 billion aggregate principal amount of Fixed-to-Fixed Rate Junior Subordinated Notes in two series (together, the “US Notes”). The US Notes were offered through a syndicate of underwriters led by CIBC Capital Markets, BMO Capital Markets, TD Securities and Wells Fargo Securities. TELUS

(TSX-V:MRZ),(Pinksheets:MRZLF),(PinkSheets:MRZLF),(AUST:PUR.AX), Pursuit Minerals acquires the Sascha-Marcelina Projects for a total consideration of ~US$1.5 million Mirasol retains a 1.5% NSR royalty. Following the commencement of commercial production, Pursuit Minerals may buy back the first 0.75% within two years for US$1.5 million, and the remaining 0.75% within three years for an additional US$4 million Repayment of CAD$2M

Mirasol Completes the Sale of the Sascha-Marcelina Projects in Argentina for US$1.5 Million Plus Royalty GlobeNewswire December 09, 2025 Pursuit Minerals acquires the Sascha-Marcelina Projects for a total consideration of ~US$1.5 million Mirasol retains a 1.5% NSR royalty. Following the commencement of commercial production, Pursuit Minerals may buy back the first 0.75% within two years

TUSTIN, Dec. 09, 2025 (GLOBE NEWSWIRE) — Agravitae, a Tustin, California-based botanical superfood company committed to research-backed products and third-party analytical verification, announced recently the publication of comprehensive analytical research demonstrating precise acetogenin concentrations in graviola (soursop) products. The study, conducted in partnership with Cambium Analytica Research Laboratories (RD-RPT-AGE-001), validates Agravitae's standardized soursop extract formulation